A003090 Stock Overview
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A003090 from our risk checks.
Daewoong Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩20,750.00 |
52 Week High | ₩27,100.00 |
52 Week Low | ₩11,460.00 |
Beta | 1.28 |
1 Month Change | -9.39% |
3 Month Change | 0.48% |
1 Year Change | 37.60% |
3 Year Change | -36.15% |
5 Year Change | 3.75% |
Change since IPO | 854.70% |
Recent News & Updates
Recent updates
With EPS Growth And More, Daewoong (KRX:003090) Is Interesting
Apr 13A Look At The Intrinsic Value Of Daewoong Co., Ltd. (KRX:003090)
Mar 29Daewoong Co., Ltd. (KRX:003090) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Mar 14Daewoong (KRX:003090) Seems To Use Debt Quite Sensibly
Feb 21The Daewoong (KRX:003090) Share Price Has Soared 308%, Delighting Many Shareholders
Jan 31Do Its Financials Have Any Role To Play In Driving Daewoong Co., Ltd.'s (KRX:003090) Stock Up Recently?
Dec 04Shareholder Returns
A003090 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | 1.2% | 4.3% | 2.4% |
1Y | 37.6% | 28.2% | 12.2% |
Return vs Industry: A003090 exceeded the KR Pharmaceuticals industry which returned 28.2% over the past year.
Return vs Market: A003090 exceeded the KR Market which returned 12.2% over the past year.
Price Volatility
A003090 volatility | |
---|---|
A003090 Average Weekly Movement | 6.4% |
Pharmaceuticals Industry Average Movement | 4.9% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.9% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A003090's share price has been volatile over the past 3 months.
Volatility Over Time: A003090's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1945 | 348 | Yeong-Hwan Yoon | https://www.daewoongholdings.com |
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd.
Daewoong Co., Ltd. Fundamentals Summary
A003090 fundamental statistics | |
---|---|
Market cap | ₩866.88b |
Earnings (TTM) | ₩152.67b |
Revenue (TTM) | ₩1.81t |
5.6x
P/E Ratio0.5x
P/S RatioIs A003090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A003090 income statement (TTM) | |
---|---|
Revenue | ₩1.81t |
Cost of Revenue | ₩883.91b |
Gross Profit | ₩929.93b |
Other Expenses | ₩777.27b |
Earnings | ₩152.67b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 3.73k |
Gross Margin | 51.27% |
Net Profit Margin | 8.42% |
Debt/Equity Ratio | 31.0% |
How did A003090 perform over the long term?
See historical performance and comparison